Brain metastases from breast cancer may respond to endocrine therapy: Report of two cases

0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

Brain metastases from breast cancer have a poor prognosis. There have been few cases reported where patients with breast cancer and brain metastases respond well to endocrine therapy (tamoxifen or letrozole). Here, we report the cases of two breast cancer patients with brain metastases who responded to medroxyprogesterone acetate and fulvestrant, respectively. These cases indicate that endocrine therapy could be very effective in the management of brain metastases from breast carcinoma.

Cite

CITATION STYLE

APA

Wang, Q., Sun, B., Liu, C., Shi, S., Ding, L., Liu, J., & Wu, S. (2019). Brain metastases from breast cancer may respond to endocrine therapy: Report of two cases. OncoTargets and Therapy, 12, 1389–1393. https://doi.org/10.2147/OTT.S188143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free